1. 1616. Mechanism of Thrombocytopenia Induced by Oxazolidinones Antibiotics (Linezolid, Tedizolid): Demonstration of Impairment of Megakaryocyte Differentiation From Human Hematopoietic Stem Cells associated with Mitochondrial Toxicity. (31st December 2020) Authors: Tulkens, Paul M; Milosevic, Tamara V; Vertenoeil, Gaëlle; Vainchenker, William; Constantinescu, Stefan N; Van Bambeke, Françoise Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Avibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients. (14th January 2015) Authors: Chalhoub, Hussein; Tunney, Michael; Elborn, J. Stuart; Vergison, Anne; Denis, Olivier; Plésiat, Patrick; Kahl, Barbara C.; Van Bambeke, Françoise; Tulkens, Paul M. Journal: Journal of antimicrobial chemotherapy Issue: Volume 70:Number 5(2015:May) Page Start: 1596 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Binding of temocillin to plasma proteins in vitro and in vivo: the importance of plasma protein levels in different populations and of co-medications. (26th August 2022) Authors: Ngougni Pokem, Perrin; Matzneller, Peter; Vervaeke, Steven; Wittebole, Xavier; Goeman, Lieven; Coessens, Marie; Cottone, Eleonora; Capron, Arnaud; Wulkersdorfer, Beatrix; Wallemacq, Pierre; Mouton, Johan W; Muller, Anouk E; Zeitlinger, Markus; Laterre, Pierre François; Tulkens, Paul M; Van Bambek... Journal: Journal of antimicrobial chemotherapy Issue: Volume 77:Number 10(2022) Page Start: 2742 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacy. (July 2015) Authors: Van Bambeke, Françoise Journal: Future microbiology Issue: Volume 10:Number 7(2015:Jul.) Page Start: 1111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria. (31st January 2017) Authors: Tam, Vincent H.; Chang, Kai-Tai; Zhou, Jian; Ledesma, Kimberly R.; Phe, Kady; Gao, Song; Van Bambeke, Françoise; Sánchez-Díaz, Ana María; Zamorano, Laura; Oliver, Antonio; Cantón, Rafael Journal: Journal of antimicrobial chemotherapy Issue: Volume 72:Number 5(2017:May) Page Start: 1421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Existing and emerging therapies for the treatment of invasive candidiasis and candidemia. (2nd October 2022) Authors: De Bels, David; Maillart, Evelyne; Van Bambeke, Françoise; Redant, Sebastien; Honoré, Patrick M. Journal: Expert opinion on emerging drugs Issue: Volume 27:Number 4(2022) Page Start: 405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. In vitro polymicrobial inter-kingdom three-species biofilm model: influence of hyphae on biofilm formation and bacterial physiology. Issue 5 (28th May 2021) Authors: Ruiz-Sorribas, Albert; Poilvache, Hervé; Kamarudin, Nur Hidayatul Nazirah; Braem, Annabel; Van Bambeke, Françoise Journal: Biofouling Issue: Volume 37:Issue 5(2021) Page Start: 481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Modulating antibiotic activity towards respiratory bacterial pathogens by co-medications: a multi-target approach. Issue 7 (July 2016) Authors: Vandevelde, Nathalie M.; Tulkens, Paul M.; Van Bambeke, Françoise Journal: Drug discovery today Issue: Volume 21:Issue 7(2016) Page Start: 1114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Modulation of the activity of moxifloxacin and solithromycin in an in vitro pharmacodynamic model of Streptococcus pneumoniae naive and induced biofilms. (23rd February 2015) Authors: Vandevelde, Nathalie M.; Tulkens, Paul M.; Muccioli, Giulio G.; Van Bambeke, Françoise Journal: Journal of antimicrobial chemotherapy Issue: Volume 70:Number 6(2015:Jun.) Page Start: 1713 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?. Issue 7 (3rd July 2017) Authors: Delattre, Isabelle K.; Taccone, Fabio S.; Jacobs, Frédérique; Hites, Maya; Dugernier, Thierry; Spapen, Herbert; Laterre, Pierre-François; Wallemacq, Pierre E.; Van Bambeke, Françoise; Tulkens, Paul M. Journal: Expert review of anti-infective therapy Issue: Volume 15:Issue 7(2017) Page Start: 677 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗